Role of Podocan and Wnt Pathway Regulatory Molecules in Coronary Artery Disease

CompletedOBSERVATIONAL
Enrollment

571

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
Coronary Artery Disease
Trial Locations (1)

13326

Bassett Healthcare Network, Cooperstown

All Listed Sponsors
collaborator

Baylor University

OTHER

lead

Jennifer Victory, RN, CCRC

OTHER

NCT02807714 - Role of Podocan and Wnt Pathway Regulatory Molecules in Coronary Artery Disease | Biotech Hunter | Biotech Hunter